novo oral glp 1 Nordisk's GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure With FDA approval of Wegovy

The weaning protocol for tirzepatide may be appropriate if you are discontinuing GLP-1 therapy entirely rather than switching

Core components that define differentiation, like adherence engines, behavioral reinforcement models, and data-driven retention systems, are almost always worth building, even if it means a higher upfront investment

Unfortunately, Lemonaid Health Weight Loss is not yet available in all 50 states

In January 2026, the MHRA approved a higher 7.2mg maximum weekly dose, followed by the introduction of a single-dose 7.2mg Wegovy pen in April 2026

Dose adjustments, meal timing changes, or anti-nausea strategies can help